Seema Harichand-Herdt MD
Hematology/Oncology at Mission Cancer + Blood University of Iowa Healthcare
Join to View Full Profile
411 Laurel StSte A300Des Moines, IA 50314
Phone+1 515-282-2921
Fax+1 515-282-1035
Dr. Harichand-Herdt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Seema Harichand-Herdt is an oncologist based in Des Moines, IA, affiliated with UnityPoint Health-Des Moines since 2017. She graduated from the University of Miami Leonard M. Miller School of Medicine in 2002 and completed her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at Emory University School of Medicine. Her expertise includes amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma. Dr. Harichand-Herdt has authored several publications on oncology topics, contributing significantly to the field, with citations reflecting the impact of her work. She has received multiple CMS Meaningful Use Stage 1 and 2 Certifications for electronic health record systems.
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2009- Emory University School of MedicineResidency, Internal Medicine, 2002 - 2005
University of Miami Leonard M. Miller School of MedicineClass of 2002
Certifications & Licensure
IA State Medical License 2017 - 2027
FL State Medical License 2010 - 2019
GA State Medical License 2004 - 2019
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MedSym EHR, MedSym, Inc., 2013-2014, 2017
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013-2014, 2017
- CMS Meaningful Use Stage 2 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2013-2014, 2017
Publications & Presentations
PubMed
- Patient-Clinician Communication: ASCO Guideline Update.Timothy Gilligan, Kari Bohlke, Ash B Alpert, Nessa Coyle, Seema Harichand-Herdt
Journal of Clinical Oncology. 2026-03-10 - 146 citationsHuman Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists GuidelineCarole Fakhry, Christina Lacchetti, Lisa M. Rooper, Richard C.K. Jordan, Danny Rischin
Journal of Clinical Oncology. 2018-09-06 - 5 citationsFinal results from phase II trial of neoadjuvant docetaxel and capecitabine given sequentially or concurrently for HER2-negative breast cancersAmelia Zelnak, Toncred M. Styblo, Monica Rizzo, Sheryl G. A. Gabram, William C. Wood
Clinical Breast Cancer. 2013-06-01
Professional Memberships
- Member
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
